Top of the morning to you. A shiny sun is warming up the Pharmalot corporate campus today where we are scrambling, as always, to get too much done in not a lot of time. Mascots to feed. Short people who need to be deposited in different locations. And an ever-growing to-do list of odds and ends and what-not. Just the same, we must stop for a cup of stimulation. How else to cope with all this? Feel free to join in. Meanwhile, here is another batch of tidbits. Have a swell day and do stay in touch...
Amarin Delays Hiring A Sales Force For Fish Oil Pill (TheStreet)
Public Citizen Asks FDA To Reinspect Compounders (Seattle Times)
Merck Cuts 56 Jobs In Canada (CJAD)
Merck In Talks To Buy MicroLabs (Financial Express)
Eli Lilly CEO Says China Is Too Slow To Approve Drugs (Bloomberg News)
FDA Panel Backs Johnson & Johnson TB Drug (Reuters)
Indian Supreme Court Says Pfizer-Cipla Case Back To Patent Office (Times of India)
South Africa Awards $667M HIV Medicine Supply Contract (Reuters)
Abbott Investors To Get One AbbVie Share For Each Abbott Share (Chicago Tribune)
Pfizer May Launch Virtual Trial Program In 2013 (Outsourcing Pharma)
Cialis Impotence Drug Helps Muscular Dystrophy Patients (Reuters)
EDITOR'S NOTE: Please check this post for updates
1 Comment